Main page
Tamro Interim Report Q1
Operating environment
BUSINESS UNITS
  Tamro Sweden
  Nomeco Denmark
  Tamro Finland
  Apokjeden Norway
  Tamro Estonia
  Tamro Latvia
  Tamro Lithuania
PHOENIX Pharma Polska, Poland
GROUP'S FINANCIAL PERFORMANCE
Investments
Financing
Personnel
Downloadable files
 

PHOENIX Pharma Polska

Total pharmaceutical sales in Poland during February–April 2009 were EUR 1,281 (1,246) million in pharmacy purchase prices (PPP). In local currency, this represents an increase of 9% compared to the same period in the previous year.

PHOENIX Pharma Polska’s net sales during February–April were EUR 70 (93) million. In local currency, the sales decreased by 2.8%. The company’s market share in the competitive wholesale market remained at 3%. The retail sector showed a positive growth trend and is the key area of focus for the full year 2009/10.

The company employed an average of 574 (380) people, of whom 35% worked in retail.

 
NET SALES
  02/09-04/09 02/08-04/08 Change 02/08-01/09
(EURm) 2009 2008 % 2008
         
PHOENIX Pharma Polska 69.9 93.4 -25.2 368.4
 
 
NUMBER OF EMPLOYEES, AVERAGE
  02/09-04/09 02/08-04/08 Change 02/08-01/09
  2009 2008 % 2008
         
PHOENIX Pharma Polska 574 380 51.1 451
 
See also:
Net sales by business unit


 

Tamro Interim Report February-April 2008. Published 4 June 2009. Copyright © 2009 Tamro Group. All rights reserved.

Design: Content Bakery.